LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.

Bioscience Reports
Shi-Qin LiuKe-Jing Zhang

Abstract

ER+ breast cancer is the most common type of breast cancer, which seriously affects the physical and mental health of women. Recently, lncRNAs mediated tumor-associated macrophages (TAM) were identified to involve in tumorigenesis. Therefore, the present study aimed at demonstrating the regulatory network of GNAS-AS1 in TAM-mediated ER+ breast cancer progress. The expression levels of genes were evaluated using qRT-PCR. The proportions of polarized macrophages (M1, M2) were assessed by flow cytometry. Cell proliferation, migration and invasion were evaluated by CCK-8, wound healing and transwell assay, respectively. Double-luciferase reporter system was used to detect the interaction between molecules. Western blot was applied to test protein levels. The expression of GNAS-AS1 was obviously increased in ER+ breast cancer tissues and cell lines, as well as M2 macrophages. GNAS-AS1 facilitated the capabilities of proliferation, migration and invasion of ER+ breast cancer cells by accelerating M2 macrophage polarization via directly sponging miR-433-3p. GATA3, as a target of miR-433-3p, could positively regulate by GNAS-AS1. Furthermore, either miR-433-3p overexpression or GATA3 knockdown impaired the effects of GNAS-AS1 on M2 mac...Continue Reading

References

Jul 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinUNKNOWN American Society of Clinical Oncology
Oct 19, 2012·Current Opinion in Endocrinology, Diabetes, and Obesity·Michael A Levine
Jun 1, 2013·Nucleic Acids Research·Luke GaughanCraig N Robson
Nov 23, 2015·Molecular Cell·Shany Koren, Mohamed Bentires-Alj
Dec 31, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Li PengGuan-Cheng Li
May 12, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Mahshid GhonchehHamid Salehiniya
Jun 30, 2016·Bioscience Reports·Yan Zhong, Chun Yi
Jan 4, 2017·Pathology·Emad A Rakha, Andrew R Green
Feb 18, 2017·Mediators of Inflammation·Sebastian R Nielsen, Michael C Schmid
Mar 6, 2017·Updates in Surgery·Zoi AnastasiadiMichail Mitsis
Mar 16, 2017·Thoracic Cancer·Ting-Ting ZuoWan-Qing Chen
May 23, 2017·Genomics, Proteomics & Bioinformatics·Iain M Dykes, Costanza Emanueli
Jul 7, 2017·Histology and Histopathology·Junjeong ChoiJa Seung Koo
May 23, 2018·Methods in Molecular Biology·Arjanneke F van de MerbelGabri van der Pluijm
Jun 15, 2018·Human Pathology·Abdul-Fattah Salah FararjehYuan-Soon Ho
Aug 31, 2018·Journal of Experimental & Clinical Cancer Research : CR·Fei XuBao-Jun Liu
Oct 3, 2018·International Journal of Molecular Sciences·Xue LiNan Li
Nov 22, 2018·Cancer Immunology Research·Ji CaoBo Yang
Jun 5, 2019·Journal of Carcinogenesis·Soley BayraktarStefan Glück
Jan 9, 2020·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jung S ByunKevin Gardner

❮ Previous
Next ❯

Citations

Feb 2, 2021·Molecular Cancer·Swati MohapatraGeorge A Calin
Nov 6, 2020·Journal of Experimental & Clinical Cancer Research : CR·Yalu ZhangQuan Liao
Jul 30, 2021·Journal of Orthopaedic Surgery and Research·Zhanhu MiPeng Ye
Aug 28, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Soudeh Ghafouri-FardMohammad Samadian

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
density gradient centrifugations
PCR
transfect
transfection
protein assay
flow cytometry
transfecting

Software Mentioned

Targetscan
GraphPad Prism

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.